Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.58 |
| ▸ | CA2 | P00918 | 3/20 | 0.58 |
| ▸ | TSHR | P16473 | 3/20 | 0.57 |
| ▸ | TP53 | P04637 | 1/20 | 0.57 |
| ▸ | PARP15 | Q460N3 | 1/20 | 0.52 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | SRD5A2 | P31213 | 3/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA3 | P07451 | 1/20 | 0.48 |
| ▸ | TYR | P14679 | 1/20 | 0.48 |
| ▸ | DRD1 | P21728 | 1/20 | 0.48 |
| ▸ | CA4 | P22748 | 1/20 | 0.48 |
| ▸ | CA6 | P23280 | 1/20 | 0.48 |
| ▸ | CA5A | P35218 | 1/20 | 0.48 |
| ▸ | CA7 | P43166 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28104658 | 0.87 | CA1 (0.50) | CA1CA2TSHRTP53PARP15 | |
| SCHEMBL2628977 | 0.84 | CA1 (0.56) | CA1CA2TSHRTP53PARP15 | |
| SCHEMBL540837 | 0.79 | PARP10 (0.64) | CA1CA2PARP15PARP10KMT2A | |
| SCHEMBL655335 | 0.79 | MAPT (0.64) | TSHRKMT2AALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL6746609 | 0.77 | TSHR (0.67) | CA1CA2TSHRTP53PARP15 | |
| SCHEMBL5581520 | 0.77 | PARP10 (0.78) | CA1CA2TSHRTP53PARP15 | |
| SCHEMBL766069 | 0.77 | PARP10 (0.78) | CA1CA2TSHRTP53PARP15 | |
| Terephthalic Acid SCHEMBL9861713 | 0.77 | PARP10 (0.78) | CA1CA2TSHRTP53PARP15 | |
| SCHEMBL22281 | 0.77 | PARP10 (0.78) | CA1CA2TSHRTP53PARP15 | |
| Terephthalic Acid SCHEMBL1655 | 0.76 | TSHR (1.00) | CA1CA2TSHRTP53SRD5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 619 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240123074-A1 | MINIMALLY TOXIC PRODRUGS | COBIORES NV (BE) | 2024-04-18 | — | — | US | claimed |
| US-11262349-B2 | Multiplexed immune cell assays on a micropillar/microwell chip platform | CLEVELAND STATE UNIVERSITY (US) | 2022-03-01 | — | — | US | claimed |
| CN-110055063-A | A kind of B, N, fluorescent orange carbon dots of S codope and its preparation method and application | 山西大学 | 2019-07-26 | — | — | CN | claimed |
| CN-110023475-A | The stabilisation of enzyme in the composition | 巴斯夫欧洲公司 | 2019-07-16 | — | — | CN | claimed |
| US-20190107532-A1 | MULTIPLEXED IMMUNE CELL ASSAYS ON A MICROPILLAR/MICROWELL CHIP PLATFORM | CLEVELAND STATE UNIVERSITY (US) | 2019-04-11 | — | — | US | claimed |
| CN-107858097-A | Super-hydrophobic fluorosilicone resin ceramic antifouling agent and preparation method thereof | 湖南辰砾新材料有限公司 | 2018-03-30 | — | — | CN | claimed |
| EP-3149138-A1 | WATER CLUSTER-DOMINANT BORONIC ACID ALKALI SURFACTANT COMPOSITIONS AND THEIR USE | The Procter & Gamble Company (US) | 2017-04-05 | — | — | EP | claimed |
| CN-103748142-B | Reversibly crosslinked micelle systems | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2016-04-27 | — | — | CN | claimed |
| WO-2015184209-A1 | WATER CLUSTER-DOMINANT BORONIC ACID ALKALI SURFACTANT COMPOSITIONS AND THEIR USE | THE PROCTER & GAMBLE COMPANY (US) | 2015-12-03 | — | — | WO | claimed |
| US-20150344817-A1 | WATER CLUSTER-DOMINANT BORONIC ACID ALKALI SURFACTANT COMPOSITIONS AND THEIR USE | THE PROCTER & GAMBLE COMPANY | 2015-12-03 | — | — | US | claimed |
| EP-1294405-A2 | PRODRUG COMPOUNDS CLEAVABLE BY THIMET OLIGOPEPTIDASE | CORIXA CORPORATION (US) | 2003-03-26 | — | — | EP | claimed |
| EP-1294404-A2 | PRODRUG COMPOUNDS WITH AN OLIGOPEPTIDE HAVING AN ISOLEUCINE RESIDUE | CORIXA CORPORATION (US) | 2003-03-26 | — | — | EP | claimed |
| EP-1294403-A2 | TRIPEPTIDE PRODRUG COMPOUNDS | CORIXA CORPORATION (US) | 2003-03-26 | — | — | EP | claimed |
| WO-2002100353-A2 | CD10-ACTIVATED PRODRUG COMPOUNDS | MEDAREX, INC. (US) | 2002-12-19 | — | — | WO | claimed |
| US-20020142955-A1 | Enzyme-cleavable prodrug compounds | E. R. SQUIBB & SONS, L.L.C. | 2002-10-03 | — | — | US | claimed |
| US-6451881-B1 | Oligomeric dispersant | MBT HOLDINGAG (CH) | 2002-09-17 | — | — | US | claimed |
| WO-2002000263-A2 | TRIPEPTIDE PRODRUG COMPOUNDS | MEDAREX, INC. (US) | 2002-01-03 | — | — | WO | claimed |
| WO-2001095943-A2 | PRODRUG COMPOUNDS WITH AN OLIGOPEPTIDE HAVING AN ISOLEUCINE RESIDUE | MEDAREX, INC. (US) | 2001-12-20 | — | — | WO | claimed |
| WO-2001095945-A2 | PRODRUG COMPOUNDS CLEAVABLE BY THIMET OLIGOPEPTIDASE | MEDAREX, INC. (US) | 2001-12-20 | — | — | WO | claimed |
| US-6133347-A | CEMENT AND A DISPERSANT COMPRISING THE REACTION PRODUCT OF A WATER SOLUBLE NONIONIC POLYMER NONADSORBING TO CEMENT PARTICLES, SUCH AS POLYOXYALKYLENE GLYCOLS, AND SPECIFIED FUNCTIONAL MOIETY THAT ADSORB ONTO A PARTICLE | MBT HOLDING AG (CH) | 2000-10-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240123074-A1 | MINIMALLY TOXIC PRODRUGS | ALG8, ALG1, LNPEP | CA1 901/4885CA2 1548/4885TSHR 4425/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.